$UBX insiders have traded $UBX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales. Here’s a ...
Unity Biotechnology (NASDAQ:UBX) just reported results for the first quarter of 2024. Unity Biotechnology reported earnings per share of -34 cents. This was above the analyst estimate for EPS of -48 ...
UNITY Biotechnology (NASDAQ:UBX) stock fell 30% after the company's mid-stage trial for its diabetic macular edema treatment did not meet main goal. The study showed that patients treated with UBX1325 ...
Unity Biotechnology (NASDAQ:UBX) lost ~48% pre-market Monday after announcing that its lead candidate UBX1325 failed to outperform Regeneron’s (REGN) blockbuster eye therapy aflibercept in a Phase 2 ...
Unity Biotechnology (UBX +10.4%) has announced to cut its workforce by ~30% to align resources on cellular senescence programs in ophthalmology and neurology and extend operating capital. Restructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results